InvestorsHub Logo
Followers 27
Posts 4686
Boards Moderated 0
Alias Born 04/30/2005

Re: None

Friday, 06/07/2024 12:54:55 PM

Friday, June 07, 2024 12:54:55 PM

Post# of 43790
Who would not opt for a no risk immunotherapy treatment which might eliminate, in whole or in part ,some cancer cells prior to undergoing surgery, radiation and/or toxic chemotherapy? My hope and prayer is that this company is successful and that millions of future sufferers will be cured or have their life span increased. The early results of the new limited study may answer the question of whether Multikine will be the new Standard of Care for sufferers of head and neck cancer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News